# Task V12: Clinical Sample Testing for SARS-CoV-2 Vaccine Candidates

> **NIH NIH N01** · BATTELLE CENTERS/PUB HLTH RES & EVALUATN · 2020 · $6,398,512

## Abstract

The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing.  These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism and emerging and re-emerging infectious diseases.

## Key facts

- **NIH application ID:** 10267386
- **Project number:** 272201800013I-0-759302000006-1
- **Recipient organization:** BATTELLE CENTERS/PUB HLTH RES & EVALUATN
- **Principal Investigator:** THOMAS RUDGE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $6,398,512
- **Award type:** —
- **Project period:** 2020-09-18 → 2022-09-17

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10267386

## Citation

> US National Institutes of Health, RePORTER application 10267386, Task V12: Clinical Sample Testing for SARS-CoV-2 Vaccine Candidates (272201800013I-0-759302000006-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10267386. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*